Immuneering Corp
NASDAQ:IMRX

Watchlist Manager

Immuneering Corp

NASDAQ:IMRX

Watchlist

Dividends

Price: 2.1 USD -0.47% Market Closed

Market Cap: 62.3m USD

Have any thoughts about
Immuneering Corp?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 2.1 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

IMRX Alert

Immuneering Corp

2.1

-0.01 (-0.47%)

52 Week Range	1.03 8.44
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Immuneering Corp

What unique competitive advantages
does Immuneering Corp hold over its rivals?

What risks and challenges
does Immuneering Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Immuneering Corp.

What unique competitive advantages
does Immuneering Corp hold over its rivals?

What risks and challenges
does Immuneering Corp face in the near future?

Has there been any significant insider trading activity
in Immuneering Corp recently?

Summarize the latest earnings call
of Immuneering Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Immuneering Corp.

Provide P/S
for Immuneering Corp.

Provide P/E
for Immuneering Corp.

Provide P/OCF
for Immuneering Corp.

Provide P/FCFE
for Immuneering Corp.

Provide P/B
for Immuneering Corp.

Provide EV/S
for Immuneering Corp.

Provide EV/GP
for Immuneering Corp.

Provide EV/EBITDA
for Immuneering Corp.

Provide EV/EBIT
for Immuneering Corp.

Provide EV/OCF
for Immuneering Corp.

Provide EV/FCFF
for Immuneering Corp.

Provide EV/IC
for Immuneering Corp.

Show me price targets
for Immuneering Corp made by professional analysts.

What are the Revenue projections
for Immuneering Corp?

How accurate were the past Revenue estimates
for Immuneering Corp?

What are the Net Income projections
for Immuneering Corp?

How accurate were the past Net Income estimates
for Immuneering Corp?

What are the EPS projections
for Immuneering Corp?

How accurate were the past EPS estimates
for Immuneering Corp?

What are the EBIT projections
for Immuneering Corp?

How accurate were the past EBIT estimates
for Immuneering Corp?

Compare the revenue forecasts
for Immuneering Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Immuneering Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Immuneering Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Immuneering Corp compared to its peers.

Compare the P/E ratios
of Immuneering Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Immuneering Corp with its peers.

Analyze the financial leverage
of Immuneering Corp compared to its main competitors.

Show all profitability ratios
for Immuneering Corp.

Provide ROE
for Immuneering Corp.

Provide ROA
for Immuneering Corp.

Provide ROIC
for Immuneering Corp.

Provide ROCE
for Immuneering Corp.

Provide Gross Margin
for Immuneering Corp.

Provide Operating Margin
for Immuneering Corp.

Provide Net Margin
for Immuneering Corp.

Provide FCF Margin
for Immuneering Corp.

Show all solvency ratios
for Immuneering Corp.

Provide D/E Ratio
for Immuneering Corp.

Provide D/A Ratio
for Immuneering Corp.

Provide Interest Coverage Ratio
for Immuneering Corp.

Provide Altman Z-Score Ratio
for Immuneering Corp.

Provide Quick Ratio
for Immuneering Corp.

Provide Current Ratio
for Immuneering Corp.

Provide Cash Ratio
for Immuneering Corp.

What is the historical Revenue growth
over the last 5 years for Immuneering Corp?

What is the historical Net Income growth
over the last 5 years for Immuneering Corp?

What is the current Free Cash Flow
of Immuneering Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Immuneering Corp.

EV/S
Enterprise Value to Sales

Current

Median

7.7

Industry

Lower than median

Lower than industry value

Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.

EV/S

Enterprise Value

-24.2m USD

Revenue

0 USD

All Countries

Forward Multiples

			Market Cap	EV/S
US	I	Immuneering Corp NASDAQ:IMRX	61.5m USD	0
FR		Pharnext SCA OTC:PNEXF	6T USD	38 083 425.9
US		Abbvie Inc NYSE:ABBV	312.7B USD	6.6
US		Amgen Inc NASDAQ:AMGN	158.3B USD	6.3
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	116.2B USD	10.2
US		Gilead Sciences Inc NASDAQ:GILD	112.4B USD	3.8
US	E	Epizyme Inc F:EPE	94.1B EUR	1 851.5
AU		CSL Ltd ASX:CSL	133.6B AUD	6.5
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	81.3B USD	5.4
US	S	Seagen Inc F:SGT	39.3B EUR	17.3
NL		argenx SE XBRU:ARGX	34.8B EUR	17.1


US	I	Immuneering Corp NASDAQ:IMRX	Average EV/S: 3 808 535.1 Not Available
FR		Pharnext SCA OTC:PNEXF	38 083 425.9
US		Abbvie Inc NYSE:ABBV	6.6
US		Amgen Inc NASDAQ:AMGN	6.3
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	10.2
US		Gilead Sciences Inc NASDAQ:GILD	3.8
US	E	Epizyme Inc F:EPE	1 851.5
AU		CSL Ltd ASX:CSL	6.5
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	5.4
US	S	Seagen Inc F:SGT	17.3
NL		argenx SE XBRU:ARGX	17.1

EV/S Forward Multiples

Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/S

N/A

2-Years Forward

EV/S

N/A

3-Years Forward

EV/S

N/A

Immuneering Corp
NASDAQ:IMRX

EV/S
Enterprise Value to Sales

EV/S Forward Multiples

See Also

Company

Help

Tools

Stocks

Immuneering Corp NASDAQ:IMRX

EV/S Enterprise Value to Sales

EV/S Forward Multiples

See Also

Company

Help

Tools

Stocks

Immuneering Corp
NASDAQ:IMRX

EV/S
Enterprise Value to Sales